Studying "secret serums" - Toward safe, effective ebola treatments

New England Journal of Medicine

Volumn 371, Issue 12, 2014, Pages 1086-1089

  Goodman, Jesse L ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AVI 7537; BCX 4430; CHLOROQUINE; DNA DIRECTED RNA POLYMERASE; IMATINIB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ZMAPP; NEW DRUG; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

DISEASE MODEL; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG RESPONSE; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; EBOLA HEMORRHAGIC FEVER; HUMAN; INFECTION CONTROL; NONHUMAN; OVERALL SURVIVAL; PROTEIN RNA BINDING; REVIEW; SURVIVAL RATE; ARTICLE; DRUG DEVELOPMENT; EPIDEMIC; MORTALITY; SERUM;

DISEASE OUTBREAKS; DRUG DISCOVERY; HEMORRHAGIC FEVER, EBOLA; HUMANS; SERUM;

EID: 84907403863     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1409817     Document Type: Article

References (6)

1. Olinger GG Jr, Pettitt J, Kim D, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A 2012;109:18030-5.
2. Pettitt J, Zeitlin L, Kim H, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med 2013;5(199):199ra113.
3. Geisbert TW, Lee AC, Robbins M, et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010;375:1896-905.
4. Iversen PL, Warren TK, Wells JB, et al. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses 2012; 4:2806-30.
5. Warren TK, Wells J, Panchal RG, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014;508:402-5.
6. Uebelhoer LS, Albariño CG, McMullan LK, et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res 2014;106:86-94.